Nephrology
Chronic Renal Failure
0
Pipeline Programs↗
0
Active Trials↗
4
Companies Involved↗
Chronic Renal Failure is an early-stage landscape with 0 programs across 4 companies. The most active players are Otsuka, Daewon Pharmaceutical Co., Ltd., Roche.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
25
clinical trials
Completed18 · 72%
Unknown status4 · 16%
Withdrawn1 · 4%
Suspended1 · 4%
Terminated1 · 4%
Clinical Trials
Trial Activity
25 trials
Isoflavones and Acute-phase Response in Chronic Renal Failure
Completed·NNational Center for Complementary and Integrative Health (NCCIH)·Phase 2·NCT00029796·52 enrolled
The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure
Completed·—·Phase 4·NCT02580474·21 enrolled
Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery
Completed·—·Phase 3·NCT01837290·60 enrolled
Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure
Completed·—·Phase 2/3·NCT00828776·62 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)